Soleus Capital Management, L.P. Neuro Pace Inc Transaction History
Soleus Capital Management, L.P.
- $1.18 Billion
- Q3 2024
A detailed history of Soleus Capital Management, L.P. transactions in Neuro Pace Inc stock. As of the latest transaction made, Soleus Capital Management, L.P. holds 2,433,168 shares of NPCE stock, worth $28.1 Million. This represents 1.44% of its overall portfolio holdings.
Number of Shares
2,433,168
Previous 2,433,168
-0.0%
Holding current value
$28.1 Million
Previous $18.4 Million
7.8%
% of portfolio
1.44%
Previous 1.86%
Shares
10 transactions
Others Institutions Holding NPCE
# of Institutions
52Shares Held
21.3MCall Options Held
1.3KPut Options Held
100-
Kck Ltd. Tortola, D85.62MShares$64.8 Million77.74% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.41MShares$39.3 Million0.56% of portfolio
-
Morgan Stanley New York, NY2.49MShares$28.8 Million0.0% of portfolio
-
Kent Lake Pr LLC Anasco, PR1.25MShares$14.4 Million3.46% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.14MShares$13.2 Million3.99% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $286M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...